Sublingual immunotherapy for house dust mite

sublingual immunotherapy (HDM) · Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sublingual immunotherapy for house dust mite, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Sublingual Immunotherapy for Allergic Rhinitis Due to House Dust Mites [Phase 2]